XTLB
Xtl Biopharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
XTLB Filings
Filing Date
Form Description
Form Type
2025-12-05
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-05 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-07-28
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-07-28 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-07-21
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-07-21 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-06-18
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
2025-06-18 ·
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
2025-06-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-06-13 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-04-30
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Financials
2025-04-30 · Financials
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025-04-07
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-04-07 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-03-04
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-03-04 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-02-03
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-02-03 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
